Company
United StatesPublic company, OTC: SGMOQSangamo Therapeutics, Inc (OTC: SGMOQ), Richmond, CA – FDA Inspections
Inspection records and compliance data for Sangamo Therapeutics, Inc in Richmond, California. 2 FDA inspections on record, last inspected July 11, 2019. Publicly traded as OTC: SGMOQ.
Company Profile
This profile covers Sangamo Therapeutics, Inc based in Richmond, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected March 7, 2011. Last inspected July 11, 2019.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 11, 2019 | NAI | Biologics · Bioresearch Monitoring | 1102899 |
| March 7, 2011 | VAI | Biologics · Bioresearch Monitoring | 711115 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Sangamo Therapeutics, Inc
Stock ticker
SGMOQ
Exchange
OTC
Price as of
November 6, 2026
FEI Number
3003795072
Address
501 Canal Blvd Ste A100, Richmond, California 94804, United States
Country
United States
ID: 9452e68e-8f35-4c52-8fa2-2d7862895727